• Preclinical pharmacology/toxicology programs to support    Phase I clinical trials
  • Expedited regulatory mechanisms
  • Regulatory strategies to gain competitive advantage
  • Rapid and uninterrupted clinical development
  • Human subjects protection
  • Strategies for combination products
  • Leveraging discovery research
  • Meeting with the FDA

 

 

Richard M. Lewis Office: 540 837 9001
      email Richard  ~ rlewis@accessbio.com

Joy A. Cavagnaro: 540 837 9002
      email Joy  ~ jcavagnaro@accessbio.com

Fax: 540 837 9003

Mailing Address:
P.O. Box 240
Boyce, Virginia 22620

All content © Access BIO, L.C. 2007-2009. All rights reserved. home | about us | services | links | contact